Isradipine (Dynacirc): L-Type Calcium Channel Blocker for Hypertension and Neuroprotection Research

Executive Summary: Isradipine (Dynacirc; CAS 75695-93-1) is a dihydropyridine L-type calcium channel blocker with high selectivity for voltage-gated calcium channels in cardiac and vascular smooth muscle cells, reducing intracellular calcium influx and enabling controlled vasodilation (Sidach & Mintz, 2000). This compound is widely used in hypertension research and neurodegenerative disease models as an intracellular calcium influx inhibitor. APExBIO supplies Isradipine (A8453) at >99.5% purity, confirmed by HPLC and NMR, for research applications (product page). Robust solubility in DMSO (≥12.55 mg/mL), ethanol, and water (with warming and sonication) ensures experimental versatility. Proper storage at -20°C is essential for compound stability and reproducibility.

Biological Rationale

Calcium signaling controls vascular tone, cardiac contractility, and neuronal excitability. Pathological increases in calcium influx contribute to hypertension, neurodegeneration, and excitotoxicity. L-type voltage-gated calcium channels (VGCCs), encoded by the CACNA1C and CACNA1D genes, are preferentially targeted by dihydropyridine (DHP) class inhibitors, such as Isradipine (Sidach & Mintz, 2000). Inhibition of these channels decreases smooth muscle contraction, leading to vasodilation and reduced systemic blood pressure. In neurons, excessive calcium influx via L-type channels is implicated in excitotoxic death, positioning Isradipine as both a cardiovascular and neuroprotective research tool. This article builds upon the mechanistic analysis in "Isradipine (Dynacirc): Advanced Insights into L-Type Calcium Channel Blockade" by providing granular solubility and storage data for experimental optimization.

Mechanism of Action of Isradipine (Dynacirc)

Isradipine is a small molecule antagonist of L-type voltage-gated calcium channels (VGCCs), specifically binding to the DHP site on the α1C and α1D subunits. Upon binding, Isradipine stabilizes the inactivated state of the channel, reducing calcium ion (Ca²⁺) entry during depolarization. This results in relaxation of vascular smooth muscle and decreased peripheral resistance. In neurons, Isradipine limits calcium-mediated excitotoxicity by attenuating sustained calcium influx. The selectivity profile has been validated via pharmacological dissection, distinguishing L-type from N-, P-, and Q-type channels using specific toxins and DHPs (Sidach & Mintz, 2000). The high affinity and specificity for L-type channels make Isradipine an indispensable tool for dissecting calcium signaling in cardiovascular and neurodegenerative disease models. For a comparative discussion of calcium channel subtype selectivity, see "Mechanistic Insight and Strategic Use of Isradipine (Dynacirc)", which this article extends by providing detailed solubility and application parameters.

Evidence & Benchmarks

• Isradipine blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac cells at nanomolar concentrations, producing vasodilation and antihypertensive effects (Sidach & Mintz, 2000).
• Pharmacological studies confirm that dihydropyridines, including Isradipine, selectively antagonize L-type channels, distinguishing them from N-, P-, and Q-type channels, as validated by toxin and DHP sensitivity assays (Sidach & Mintz, 2000).
• Isradipine exhibits robust solubility: ≥12.55 mg/mL in DMSO, ≥16.43 mg/mL in ethanol (with ultrasonic assistance), and ≥2.71 mg/mL in water (with gentle warming and ultrasonic treatment), supporting diverse assay formats (APExBIO product page).
• Stability is maximized when stored at -20°C; solutions are not recommended for long-term storage and should be used promptly for reproducibility (APExBIO product page).
• The product is supplied at >99.5% purity, confirmed via HPLC and NMR, enabling high-confidence research applications (APExBIO product page).
• Recent studies employ Isradipine in neuroprotective assays to mitigate calcium-mediated neuronal injury in excitotoxic models (Azamethiphos Assay Article).

Applications, Limits & Misconceptions

Isradipine (Dynacirc) is validated for:

• Hypertension research via vascular smooth muscle relaxation and blood pressure reduction.
• Neurodegenerative disease models targeting calcium-mediated excitotoxicity.
• Dissecting L-type calcium channel function in cardiovascular, neuronal, and smooth muscle systems.
• Assay optimization in cell-based and tissue-based models requiring precise intracellular calcium modulation.

This article updates the workflow focus in "Isradipine (Dynacirc) for Reliable Calcium Channel Blockade" by providing explicit preparation and storage protocols for the research community.

Common Pitfalls or Misconceptions

• Isradipine is highly selective for L-type channels; it does not inhibit N-, P-, or Q-type channels at research-relevant concentrations (Sidach & Mintz, 2000).
• The compound is for research use only; it is not approved for clinical or diagnostic applications (product page).
• Long-term storage of prepared solutions is not recommended; instability may compromise activity.
• Solubility is optimal in DMSO and ethanol; aqueous solubility requires warming and sonication and is limited compared to organic solvents.
• Off-target effects may occur at supraphysiological concentrations; titration and appropriate controls are essential.

Workflow Integration & Parameters

APExBIO’s Isradipine (Dynacirc), SKU A8453, is supplied as a solid with a molecular weight of 371.39 g/mol and formula C₁₉H₂₁N₃O₅. For 10 mM stock preparation, dissolve 3.71 mg in 1 mL anhydrous DMSO. Ensure complete dissolution by gentle vortexing or brief sonication. For ethanol-based stocks, ≥16.43 mg/mL solubility can be achieved with ultrasonic assistance. If aqueous solutions are required, gentle warming and sonication are mandatory to reach up to 2.71 mg/mL. Store dry powder at -20°C and use freshly prepared solutions. Avoid repeated freeze-thaw cycles. Confirm solution clarity before use. For optimal performance, use HPLC- or NMR-confirmed high-purity lots. For more discussion on experimental integration, see "Isradipine (Dynacirc): Mechanistic Insights and Strategic Integration", which this article supplements with updated solubility and purity data.

Conclusion & Outlook

Isradipine (Dynacirc) from APExBIO is a benchmark L-type voltage-gated calcium channel antagonist, enabling targeted modulation of calcium signaling in hypertension and neurodegenerative research paradigms. The compound’s high selectivity, purity, and solubility facilitate reproducible experimentation and robust data generation. Ongoing research continues to expand its applications in mechanistic studies of calcium channelopathies and neuroprotection. For full technical details and ordering, refer to the Isradipine (Dynacirc) A8453 product page.